Isbn: 9781032242453 - biomarker analysis in clinical trials with r (chapman & hall/crc biostatistics series) (18 resultados)

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New.

Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.

Condición: New.

Condición: New. 1st edition NO-PA16APR2015-KAP.

Condición: As New. Unread book in perfect condition.

Condición: New.

Paperback. Condición: New.

Condición: New.

Condición: New. In English.

Paperback. Condición: Brand New. 204 pages. 9.19x6.13x0.52 inches. In Stock.

Taschenbuch. Condición: Neu. Biomarker Analysis in Clinical Trials with R | Nusrat Rabbee | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2021 | Chapman and Hall/CRC | EAN 9781032242453 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.…

PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The world is awash in data. This volume of data will continue to increase. In the pharmaceutical industry, much of this data explosion has happened around biomarker data. Great statisticians are needed to derive understanding from these data. This book will guide you as you begin the journey into communicating, understanding and synthesizing biomarker data. -From the Foreword, Jared Christensen, Vice President, Biostatistics Early Clinical Development, Pfizer, Inc.Biomarker Analysis in Clinical Trials with R offers practical guidance to statisticians in the pharmaceutical industry on how to incorporate biomarker data analysis in clinical trial studies. The book discusses the appropriate statistical methods for evaluating pharmacodynamic, predictive and surrogate biomarkers for delivering increased value in the drug development process. The topic of combining multiple biomarkers to predict drug response using machine learning is covered. Featuring copious reproducible code and examples in R, the book helps students, researchers and biostatisticians get started in tackling the hard problems of designing and analyzing trials with biomarkers.Features:Analysis of pharmacodynamic biomarkers for lending evidence target modulation.Design and analysis of trials with a predictive biomarker.Framework for analyzing surrogate biomarkers.Methods for combining multiple biomarkers to predict treatment response.Offers a biomarker statistical analysis plan.R code, data and models are given for each part: including regression models for survival and longitudinal data, as well as statistical learning models, such as graphical models and penalized regression models. 230 pp. Englisch.…

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Nusrat Rabbee is a biostatistician and data scientist at Rabbee &amp Associates, where she creates innovative solutions to help companies accelerate drug and diagnostic development for patients. Her research interest lies in the interse.…

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The world is awash in data. This volume of data will continue to increase. In the pharmaceutical industry, much of this data explosion has happened around biomarker data. Great statisticians are needed to derive understanding from these data. This book will guide you as you begin the journey into communicating, understanding and synthesizing biomarker data. -From the Foreword, Jared Christensen, Vice President, Biostatistics Early Clinical Development, Pfizer, Inc.Biomarker Analysis in Clinical Trials with R offers practical guidance to statisticians in the pharmaceutical industry on how to incorporate biomarker data analysis in clinical trial studies. The book discusses the appropriate statistical methods for evaluating pharmacodynamic, predictive and surrogate biomarkers for delivering increased value in the drug development process. The topic of combining multiple biomarkers to predict drug response using machine learning is covered. Featuring copious reproducible code and examples in R, the book helps students, researchers and biostatisticians get started in tackling the hard problems of designing and analyzing trials with biomarkers.Features:Analysis of pharmacodynamic biomarkers for lending evidence target modulation.Design and analysis of trials with a predictive biomarker.Framework for analyzing surrogate biomarkers.Methods for combining multiple biomarkers to predict treatment response.Offers a biomarker statistical analysis plan.R code, data and models are given for each part: including regression models for survival and longitudinal data, as well as statistical learning models, such as graphical models and penalized regression models.…